These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 71601)

  • 21. [Changes in systemic blood viscosity in subjects with regional chronic vasculopathies during spontaneous and induced ischemia].
    Di Perri T; Forconi S; Guerrini M; Rossi C; Pecchi S
    Boll Soc Ital Cardiol; 1977; 22(7):1138-50. PubMed ID: 618247
    [No Abstract]   [Full Text] [Related]  

  • 22. Early rheological and microcirculatory changes in children with type I diabetes mellitus.
    Koscielny J; Latza R; Wolf S; Kiesewetter H; Jung F
    Clin Hemorheol Microcirc; 1998 Oct; 19(2):139-50. PubMed ID: 9849927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biorheological views of diabetic macroangiopathy].
    Uchimura I
    Nihon Rinsho; 2006 Nov; 64(11):2159-63. PubMed ID: 17087312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP; Michal M
    Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
    [No Abstract]   [Full Text] [Related]  

  • 25. Erythropoietin in diabetic macular edema and renal insufficiency.
    Friedman EA; Brown CD; Berman DH
    Am J Kidney Dis; 1995 Jul; 26(1):202-8. PubMed ID: 7611253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic effect of lipo PGE1 on diabetic neuropathy-changes in endothelin and various angiopathic factors.
    Itoh Y; Yasui T; Kakizawa H; Makino M; Fujiwara K; Kato T; Imamura S; Yamamoto K; Hishida H; Nakai A; Itoh M; Nagasaka A
    Prostaglandins Other Lipid Mediat; 2001 Oct; 66(3):221-34. PubMed ID: 11577785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations].
    Benhamou PY; Carpentier P; Halimi S; Bertrand C; Mouillon M; Franco A
    Diabete Metab; 1990; 16(3):192-8. PubMed ID: 2210013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome.
    Mavrakanas T; Frachebois C; Soualah A; Aloui F; Julier I; Bastide D
    Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased platelet aggregation in diabetes mellitus.
    Kwaan HC; Colwell JA; Cruz S; Suwanwela N; Dobbie JG
    J Lab Clin Med; 1972 Aug; 80(2):236-46. PubMed ID: 5044780
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma thrombomodulin: a marker for microvascular complications in diabetes mellitus.
    Gabat S; Keller C; Kempe HP; Amiral J; Ziegler R; Ritz E; Bergis KH; Wahl P; Nawroth P
    Vasa; 1996; 25(3):233-41. PubMed ID: 8795304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients.
    Tai TY; Tseng CH; Sung SM; Huang RF; Chen CZ; Tsai SH
    J Formos Med Assoc; 1991 Oct; 90(10):936-40. PubMed ID: 1685173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyperglycemia as a cause of diabetic complications].
    Wieland OH
    Verh Dtsch Ges Inn Med; 1987; 93():187-93. PubMed ID: 3442101
    [No Abstract]   [Full Text] [Related]  

  • 34. Diabetes mellitus: can we reduce the complications?
    Malins JM
    J R Coll Physicians Lond; 1976 Apr; 10(3):289-93. PubMed ID: 1263165
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus.
    Norymberg C; Shenkman L
    Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.
    Looker HC; Fagot-Campagna A; Gunter EW; Pfeiffer CM; Narayan KM; Knowler WC; Hanson RL
    Diabetologia; 2003 Jun; 46(6):766-72. PubMed ID: 12774164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study.
    West KM; Ahuja MM; Bennett PH; Grab B; Grabauskas V; Mateo-de-Acosta O; Fuller JH; Jarrett RJ; Keen H; Kosaka K; Krolewski AS; Miki E; Schliack V; Teuscher A
    Diabetologia; 1982 Jun; 22(6):412-20. PubMed ID: 7049799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of plasma ascorbate in diabetic microangiopathy.
    Ali SM; Chakraborty SK
    Bangladesh Med Res Counc Bull; 1989 Dec; 15(2):47-59. PubMed ID: 2629696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between serum magnesium and common complications of diabetes mellitus.
    Zhang Y; Li Q; Xin Y; Lv W; Ge C
    Technol Health Care; 2018; 26(S1):379-387. PubMed ID: 29758962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.